This week in transparency news: October 19 – November 1, 2019

by Donald McLean, MBA,
Posted on 11/1/2019

Transparency in clinical trials is continually changing, and to stay on top of the news, TrialAssure brings a weekly round-up of some of the key stories surrounding disclosures in clinical trials. This week’s stories are as follows:

European Medicines Agency pledges to make clinical trial reporting easier for universities TranspariMED

The European Medicines Agency has announced plans to make it easier for universities and smaller pharma companies to upload the results of clinical trials of medicines onto the European trial registry EudraCT. At a European Parliament event organized by Health Action International and TranspariMED, the EMA said it will improve compliance and make trial reporting easier.

Till Bruckner has the full story

EU clinical trial transparency under fire FDAnews

The EMA is concerned about the state of clinical trial transparency in the EU due to a pending court ruling that has the potential to set a precedent against data-sharing. On appeal, the EU Court of Justice said that the pharmaceutical companies did not have to publish their results.

Read the story in FDAnews

Canada makes clinical trial data available to publicSpectrum News

In March of this year, Health Canada began making clinical trial information publicly available through its online government portal. Thus far, reports have been made available for four newly approved drugs.

Read the full article by Barbara Mantel

Good Pharma Scorecard continues to boost clinical trial transparency, analyst report shows BioSpace

According to analyst firm GlobalData, Bioethics International’s Good Pharma Scorecard has been an impactful driver of increased transparency. Since the scorecard first began, transparency scores have consistently risen year-over-year.

Alex Keown has the details here

Share: